Skip to main content
. 2012 Nov 29;141(9):1983–1992. doi: 10.1017/S0950268812002476

Table 1.

Antibiotic susceptibilities of methicillin-resistant Staphylococcus aureus isolates from colonized patients in paediatric intensive-care units

Year No. of MRSA isolates Erythromycin (% susceptible) Gentamicin (% susceptible) Tetracycline (% susceptible) TMP/SMX (% susceptible) Clindamycin (% susceptible) Inducible clindamycin resistance (%)*
2001 21 9·5 52·4 52·4 57·1 4·8 10·0
2002 21 9·5 76·2 66·7 91·7 25 13·3
2003 28 3·6 100·0 96·4 100·0 11·5 26·1
2004 38 13·2 92·1 92·1 97·2 29·7 61·5
2005 26 11·5 96·2 92·3 96·0 30·8 38·9
2006 60 11·7 100·0 96·7 100·0 35 46·2
2007 73 8·2 98·6 91·8 95·9 28·8 48·1
2008 93 20·4 95·7 91·4 96·8 44·1 44·2
2009 91 8·8 98·9 97·8 98·9 50·6 57·8
Total 451 11·8 94·5 90·9 95·4 35·1 43·0
P value 0·33 <0·001 <0·001 <0·001 <0·001 <0·001
*

Proportion of clindamycin-resistant isolates with inducible resistance. Denominators for each year are 20, 16, 23, 26, 18, 39, 52, 52 and 45, respectively.

Number of MRSA isolates tested for susceptibility to TMP/SMX was 12 in 2002, four in 2003, 36 in 2004 and 25 in 2005.

P value for trends calculated using the Cochran–Armitage trend test.